Literature DB >> 33110549

Determination of the emergency phase for response against endemic disease outbreak: A case of Lassa fever outbreak in Nigeria.

Oladipupo Ipadeola1, Yuki Furuse2,3, Tanyth de Gooyer2,4, Chioma Dan-Nwafor5, Geoffrey Namara2, Elsie Ilori5, Chikwe Ihekweazu5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33110549      PMCID: PMC7568005          DOI: 10.7189/jogh.10.020353

Source DB:  PubMed          Journal:  J Glob Health        ISSN: 2047-2978            Impact factor:   4.413


× No keyword cloud information.
Since 2017, Nigeria has experienced large outbreaks of Lassa fever (LF) [1,2]. The Nigeria Centre for Disease Control (NCDC) activated its Emergency Operations Centre for the outbreak response. However, it was difficult to determine the emergency phase for LF outbreak response because of its endemicity. Because there are ongoing sporadic LF cases throughout the year [2], a single case of the disease cannot be the trigger to determine the emergency phase of LF such as the case of Ebola [3]. The World Health Organization advocated the use of alerts for malaria when weekly cases exceed the 75th percentile of cases from the same week in previous years [4]. However, applying similar thresholds for LF seems too low to implement intensive response in resource-limiting setting. Additionally, the thresholds do not take consideration of the capacity of response activity itself. Here, we describe the development of composite indicators to determine the emergency phase for LF outbreak response in Nigeria. The composite indicators consist of seven criteria to reflect the outbreak situation from various aspects.

COMPOSITE INDICATORS FOR EMERGENCY PHASE FOR OUTBREAK RESPONSE

1. Number of confirmed cases

Emergency phase designation criteria thresholds were developed using statistical criteria [2]. The thresholds were developed as the mean plus two standard deviations of the weekly number of confirmed cases for the period of 2 weeks before and after a particular week in the past 3 years (eg, data from week 3-7 in 2016-2018 for the development of threshold for week 5 in 2019). This accounts for variation in LF incidence throughout the year and the previous years.

2. Number of states with cases exceeding bed capacity

Even if the number of confirmed cases at the national level was below the threshold defined in criterion 1, the outbreak could surpass local health care capacity. Therefore, we monitored the number of cases against bed capacity in LF treatment center at the state level.

3. Number of suspected cases

The number of confirmed cases would be less meaningful if there was no adequate surveillance activity to detect LF cases. Therefore, the number of suspected cases including both laboratory-confirmed and laboratory-negative cases was monitored to ascertain sufficient surveillance activity. To consider seasonal fluctuation of the disease, the lower thresholds were developed as the mean minus one standard deviation of the number of suspected cases in the past 3 weeks in the same year.

4. Case fatality rate

Timely and appropriate medical care, such as ribavirin administration and renal dialysis, was reported to improve prognosis of patients with LF [1,5]. Unexpectedly high case fatality rate indicates malfunction of the health care system such as delayed referral to treatment center and poor compliance with case management guidelines [5]. We monitored weekly case fatality rate and compared it with that in the previous year.

5. Infection among health care workers

Nosocomial human-to-human transmission of the disease can be prevented by appropriate standard precaution strategy. The criterion is met when there are ≥2 confirmed cases among health care workers.

6. Safe burial

Unsafe burial is considered to be a mode of secondary transmission of viral hemorrhagic fever. National guidelines stated that a safe and dignified burial should be conducted for every LF corpse by designated safe burial team [5]. There should be no unsafe burial of LF patient.

7. Turnaround time of laboratory test

Timely diagnosis of LF is important for better clinical management of patients and for prevention of further spread of the disease. Although in Nigeria, a national network of laboratories covers the entire country for LF diagnosis, the surge of submission of samples during outbreak affected sample transportation and diagnostic test, resulting in the delay in turnaround time for diagnostic results. We monitored the proportion of samples in which the time from sample collection to diagnostic test report was ≥48 hours and compared this proportion with that observed in the previous year. Photo: Meetings on Lassa fever outbreak response with national and local health authorities and partners (from the authors’ own collection, used with permission).

APPLICATION OF INDICATORS AND INTERPRETATION OF EMERGENCY

Using the seven composite indicators, “Emergency” of the outbreak was defined as either “criterion 1 and one more criterion” or “three or more of criterion 2–7.” shows the situation of LF outbreak in 2019. Emergency phase started from week 3, and the emergency phase was declared over when there was no “emergency” in 4 consecutive weeks (week 22). The NCDC have used this approach to declare the emergency phase and its containment to change intensity of outbreak response. This kind of composite indicators considering various aspects of an outbreak could be useful to determine emergency phase not only for LF but also for other endemic diseases. Determination of emergency phase for outbreak response would enable us to effectively and efficiently allocate resources particularly in resource-limiting settings.
Table 1

Composite indicators and situation of Lassa fever outbreak in Nigeria in 2019

Wk 1Wk 2
Wk 3
Wk 4
Wk 5
Wk 6
Wk 7
Wk 8
Wk 9
Wk 10
Wk 11
Wk 12
Wk 13
Wk 14
Wk 15
Wk 16
Wk 17
Wk 18
Wk 19
Wk 20
Wk 21
Wk 22
Wk 23
Wk 24
Criterion 1
Indicator
Number of confirmed cases*
25
35
74
77
68
37
25
23
39
52
23
15
16
11
3
6
8
11
4
6
3
3
6
4
Threshold
Calculated from data in the past 3 years
38
42
44
48
61
64
64
62
59
44
30
17
16
16
13
10
9
7
7
6
6
5
8
9
Criterion met?


YES
YES
YES




YES


YES




YES

YES




Criterion 2
Indicator
Number of states with cases exceeding bed capacity
0
0
3
4
3
1
1
1
1
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Threshold
Fixed
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Criterion met?


YES
YES
YES




YES














Criterion 3†
Indicator
Number of suspected cases*
64
130
170
193
217
200
163
119
182
215
152
137
126
88
84
90
59
79
77
100
100
65
67
65
Lower threshold
Calculated from data in the past 3 weeks
65
59
48
67
132
169
190
165
120
122
123
151
126
125
91
76
84
61
60
60
72
79
68
57
Criterion met?
YES





YES
YES



YES
YES
YES
YES

YES




YES
YES

Criterion 4
Indicator
Case fatality rate (%)
28.0
22.9
18.9
14.3
20.6
27.0
24.0
26.1
20.5
21.2
17.4
33.3
12.5
9.1
0
0
12.5
36.4
0
16.7
0
33.3
16.7
25.0
Threshold
Data from the previous year
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
25.0
Criterion met?
YES




YES

YES



YES





YES



YES

YES
Criterion 5
Indicator
Number of confirmed cases among healthcare workers
0
0
1
1
4
3
1
1
0
0
1
0
1
0
0
0
1
0
0
0
0
0
0
0
Threshold
Fixed
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Criterion met?




YES
YES


















Criterion 6
Indicator
Number of unsafe burial
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Threshold
Fixed
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Criterion met?
























Criterion 7
Indicator
Proportion of samples that took ≥48 hours from sample collection to diagnostic test report (%)
20.3
26.0
20.0
17.6
17.9
19.0
19.5
29.5
15.6
10.3
15.2
22.0
17.2
12.0
28.8
14.9
17.5
17.9
12.7
10.9
13.3
15.6
12.3
9.4
Threshold
Data from the previous year
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
22.0
Criterion met?

YES





YES



YES


YES









Emergency defined by the composite indicators‡


YES
YES
YES


YES

YES

YES
YES




YES






Emergency phase‡


Start
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
Ong.
(End) §
Ong.
Ong.
Ong.
Ong.
End


Wk – week, Ong. – ongoing

*The definition of suspected and confirmed LF cases used for the indicators was described elsewhere [1].

†Criterion 3 is met when indicator is ≤ the thresholds. For others, each criterion is met when indicator is ≥ the thresholds.

‡Interpretation of composite indicators to define emergency phase is explained in detail in the main texts.

§According to the definition, week 17 should have been the end of the emergency phase. However, the containment of emergency phase was not declared then because resurge of the number of cases was recognized during week 18 before completion of assessment for week 17.

Composite indicators and situation of Lassa fever outbreak in Nigeria in 2019 Wk – week, Ong. – ongoing *The definition of suspected and confirmed LF cases used for the indicators was described elsewhere [1]. †Criterion 3 is met when indicator is ≤ the thresholds. For others, each criterion is met when indicator is ≥ the thresholds. ‡Interpretation of composite indicators to define emergency phase is explained in detail in the main texts. §According to the definition, week 17 should have been the end of the emergency phase. However, the containment of emergency phase was not declared then because resurge of the number of cases was recognized during week 18 before completion of assessment for week 17.
  2 in total

1.  Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.

Authors:  Elsie A Ilori; Yuki Furuse; Oladipupo B Ipadeola; Chioma C Dan-Nwafor; Anwar Abubakar; Oboma E Womi-Eteng; Ephraim Ogbaini-Emovon; Sylvanus Okogbenin; Uche Unigwe; Emeka Ogah; Olufemi Ayodeji; Chukwuyem Abejegah; Ahmed A Liasu; Emmanuel O Musa; Solomon F Woldetsadik; Clement L P Lasuba; Wondimagegnehu Alemu; Chikwe Ihekweazu
Journal:  Emerg Infect Dis       Date:  2019-06       Impact factor: 6.883

2.  Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.

Authors:  Chioma C Dan-Nwafor; Yuki Furuse; Elsie A Ilori; Oladipupo Ipadeola; Kachikwulu O Akabike; Anthony Ahumibe; Winifred Ukponu; Lawal Bakare; Tochi J Okwor; Gbenga Joseph; Nwando G Mba; Adejoke Akano; Adebola T Olayinka; Ihekerenma Okoli; Rita A Okea; Favour Makava; Nkem Ugbogulu; Saliu Oladele; Geoffrey Namara; Esther N Muwanguzi; Dhamari Naidoo; Samuel K Mutbam; Ifeanyi Okudo; Solomon F Woldetsadik; Clement Lp Lasuba; Chikwe Ihekweazu
Journal:  Euro Surveill       Date:  2019-05
  2 in total
  2 in total

Review 1.  Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review.

Authors:  John-Ugwuanya A Grace; Ifunanya J Egoh; Nnenna Udensi
Journal:  Ther Adv Infect Dis       Date:  2021-11-29

Review 2.  The One Health approach to incident management of the 2019 Lassa fever outbreak response in Nigeria.

Authors:  Chioma Dan Nwafor; Elsie Ilori; Adebola Olayinka; Chinwe Ochu; Rosemary Olorundare; Edwin Edeh; Tochi Okwor; Oyeronke Oyebanji; Esther Namukose; Winifred Ukponu; Michael Olugbile; Usman Adekanye; Nastassya Chandra; Hikaru Bolt; Geofrey Namara; Oladipupo Ipadeola; Yuki Furuse; Solomon Woldetsadik; Adejoke Akano; Akanimo Iniobong; Michael Amedu; Chimezie Anueyiagu; Lawal Bakare; Anthony Ahumibe; Gbenga Joseph; Chibuzo Eneh; Muhammad Saleh; Naidoo Dhamari; Ihekerenma Okoli; Mairo Kachalla; Rita Okea; Collins Okenyi; Favour Makava; Catherine Makwe; Nkem Ugbogulu; Fritz Fonkeng; Everistus Aniaku; Emmanuel Agogo; Nwando Mba; Olusola Aruna; Patrick Nguku; Chikwe Ihekweazu
Journal:  One Health       Date:  2021-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.